Table 3. Demographic data group by waist circumference (n = 4589).

Variable	Waist < 88 for male, Waist < 83 for female	Waist 88-93.14 for male, Waist 83-88.99 for female	Waist 93.15-99.99 for male, Waist 89-95.99 for female	Waist ≥ 100 for male, Waist ≥ 96 for female	p-value
	n = 1138	n = 1126	n = 1128	n = 1191
Age (year), mean ± SD	66.27 ± 11.20	65.78 ± 11.16	66.46 ± 11.23	65.51 ± 12.15	0.04
Male (%)	73.46	75.49	71.10	74.31	0.11
Waist (cm), mean ± SD	81.06 ± 5.07	89.35 ± 2.64	95.00 ± 2.74	105.27 ± 6.38	< 0.01
Hip (cm), mean ± SD	92.21 ± 5.58	97.00 ± 5.19	100.79 ± 5.61	107.35 ± 7.75	< 0.01
WHR, mean ± SD	0.88 ± 0.060	0.92 ± 0.057	0.95 ± 0.061	0.98 ± 0.081	< 0.01
Weight (kg), mean ± SD	60.44 ± 8.11	66.51 ± 8.25	70.95 ± 9.25	81.05 ± 12.06	< 0.01
Height (cm), mean ± SD	161.77 ± 7.64	162.44 ± 7.99	163.02 ± 8.26	164.28 ± 8.55	< 0.01
BMI (kg/m2), mean ± SD	23.08 ± 2.45	25.17 ± 2.30	26.70 ± 2.65	30.03 ± 3.71	< 0.01
History of HTN (%)	69.04	71.29	73.32	79.60	< 0.01
History of DM (%)	29.61	35.00	37.76	39.53	< 0.01
History of ischemic stroke (%)	12.92	14.65	10.37	9.57	< 0.01
History of MI (%)	77.59	76.38	79.88	79.43	0.15
Current smoker (%)	15.64	15.99	15.60	16.88	0.82
Statin use (%)	67.22	66.52	67.64	64.99	0.54
Fibrate use (%)	2.9	5.5	4.9	8.2	< 0.01
Anti-platelets therapy use (%)	85.50	85.17	85.46	83.38	0.42
ARB or ACEI use (%)	54.31	56.57	63.21	65.49	< 0.01
Beta-blockers use (%)	45.78	47.87	52.13	52.64	< 0.01
CKD (eGFR < 30)	2.34	2.46	2.17	2.64	0.92
TC (mg/dL), mean ± SD	174.16 ± 41.76	172.24 ± 38.53	170.03 ± 37.57	170.80 ± 37.82	0.07
HDL-C (mg/dL), mean ± SD	49.10 ± 15.31	45.96 ± 13.80	44.78 ± 12.19	42.86 ± 12.15	< 0.01
LDL-C (mg/dL), mean ± SD	99.88 ± 37.37	98.66 ± 33.71	96.90 ± 32.61	97.99 ± 32.77	0.25
TG (mg/dL), mean ± SD	124.35 ± 95.98	138.29 ± 81.91	143.35 ± 84.47	154.68 ± 94.28	< 0.01

Abbreviation as Table 1.